CNTB
Connect Biopharma Holdings
CNTB
CNTB
28 hedge funds and large institutions have $53.4M invested in Connect Biopharma Holdings in 2022 Q1 according to their latest regulatory filings, with 9 funds opening new positions, 12 increasing their positions, 5 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
39% less capital invested
Capital invested by funds: $87.4M → $53.4M (-$34M)
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $32K
Holders
28
Holding in Top 10
–
Calls
–
Puts
$32K
Top Buyers
| 1 | +$3.53M | |
| 2 | +$1.8M | |
| 3 | +$1.26M | |
| 4 |
Barclays
London,
United Kingdom
|
+$947K |
| 5 |
KCM
Kynam Capital Management
Princeton,
New Jersey
|
+$688K |
Top Sellers
| 1 | -$3.42M | |
| 2 | -$3.33M | |
| 3 | -$1.03M | |
| 4 |
ACM
Altium Capital Management
New York
|
-$901K |
| 5 |
Marshall Wace
London,
United Kingdom
|
-$634K |